Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 11/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | INSR | P06213 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10068872 | 0.82 | INSR (0.44) | NPSR1INSRKDM4EGAAL3MBTL1 | |
| SCHEMBL13822181 | 0.82 | PDE3B (0.49) | KDM4EKMT2ALMNAMAPTSMN1; SMN2 | |
| SCHEMBL10069295 | 0.79 | INSR (0.40) | NPSR1INSRKDM4EGAAL3MBTL1 | |
| SCHEMBL13126958 | 0.78 | ALOX5 (0.41) | ACHENPSR1KDM4EPOLBKMT2A | |
| SCHEMBL14536918 | 0.77 | SNCA (0.54) | ACHEKDM4EKMT2AMAPTSMN1; SMN2 | |
| SCHEMBL13126898 | 0.76 | NFE2L2 (0.48) | ACHEINSRGAAPOLBKMT2A | |
| Hydrochloric Acid SCHEMBL3451810 | 0.76 | SNCA (0.53) | ACHEKDM4EKMT2AMAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL712985 | 0.76 | SNCA (0.53) | ACHEKDM4EKMT2AMAPTSMN1; SMN2 | |
| SCHEMBL10069275 | 0.75 | INSR (0.37) | NPSR1INSRKDM4EGAAL3MBTL1 | |
| SCHEMBL10069282 | 0.74 | ACHE (0.68) | ACHEKDM4EGAAL3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820696-B2 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| US-7547444-B1 | Methods for controlling fungi and bacteria | MYCOSOL, INC. (US) | 2009-06-16 | — | — | US | disclosed |
| US-20090137639-A1 | METHODS FOR CONTROLLING FUNGI AND BACTERIA | MYCOSOL, INC. | 2009-05-28 | — | — | US | disclosed |
| EP-1601652-B1 | PYRIDINIUM SALTS, COMPOUNDS AND METHODS OF USE | MYCOSOL INC (US) | 2008-07-30 | — | — | EP | disclosed |
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | MYCOSOL, INC. | 2007-09-13 | — | — | US | disclosed |
| US-7220761-B2 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. (US) | 2007-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | BLVRB, PNPO, PLPBP | ACHE 39/4885NPSR1 3591/4885INSR 3656/4885 |
| US-20090137639-A1 | METHODS FOR CONTROLLING FUNGI AND BACTERIA | PNPO, BLVRB, DPM1 | ACHE 289/4885NPSR1 3197/4885INSR 3997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.